About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Georgia | 476 Studies

Clinical Trials LymphomaGeorgia

Lymphoma Clinical Trials in Georgia

Find 476 clinical trials for lymphoma near Georgia. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Georgia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 181-200 of 476 trials

TerminatedA Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose ChemotherapyThe purpose of this study is to evaluate the efficacy of inotuzumab ozogamicin plus rituximab in relapsed/refractory aggressive Non-Hodgkin lymphoma patients who are not…NCT01232556·Burbank, California and 176 others

PreviousPage 10 of 24Next

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)This study has 2 parts.NCT05020015·Birmingham, Alabama and 14 others

UnknownXcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) PatientsThis is a Phase II single arm study of a novel T cell immunotherapy in patients with indolent non-Hodgkin's lymphoma (NHL).NCT00081783·Greenbrae, California and 17 others

CompletedCollecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin LymphomaThis research study is collecting and storing tissue samples from patients with rare or cutaneous non-Hodgkin lymphoma.NCT01000753·Birmingham, Alabama and 129 others

CompletedTisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin LymphomaThis is a randomized, open label, multicenter phase III trial comparing the efficacy, safety, and tolerability of tisagenlecleucel to Standard Of Care in adult patients with…NCT03570892·La Jolla, California and 66 others

CompletedAllogeneic Transplant in HIV Patients (BMT CTN 0903)The rationale for this trial is to demonstrate the feasibility and safety of allogeneic HCT for patients with chemotherapy-sensitive hematological malignancies and coincident…NCT01410344·Phoenix, Arizona and 10 others

CompletedVaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantThis randomized phase II trial studies how well vaccine therapy works in reducing the frequency of cytomegalovirus severe infections (events) in patients with hematologic…NCT02396134·Duarte, California and 4 others

TerminatedA Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin LymphomaThis is a Phase I open-label, multicenter study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary activity of tiragolumab…NCT04045028·Denver, Colorado and 13 others

CompletedBone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)Bone marrow transplants are one treatment option for people with leukemia or lymphoma.NCT00849147·Duarte, California and 16 others

CompletedSupersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell TransplantThis randomized phase III trial is studying how well Caphosol rinse works in preventing mucositis in young patients undergoing autologous or donor stem cell transplant.NCT01305200·Arcadia, California and 34 others

TerminatedDonor Stem Cell Transplant in Treating Patients With High-Risk Hematologic CancerRATIONALE: Giving low doses of chemotherapy before a donor stem cell transplant helps stop the growth of cancer cells.NCT00818961·Atlanta, Georgia

RecruitingA Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin LymphomaStudy J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed originator study, clinical study…NCT06876662·Miami, Florida and 35 others

TerminatedStudy of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) SubjectsA study in subjects with a type of B cell lymphoma (DLBCL)to evaluate the response rate, efficacy, safety and tolerability of YM155NCT00498914·Beverly Hills, California and 21 others

CompletedA Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin LymphomaThis is a Phase 1, first-in-human, open-label, multicenter study of CC-97540, CD19-targeted NEX-T chimeric antigen receptor (CAR) T cells, in subjects with relapsed or refractory…NCT04231747·Birmingham, Alabama and 13 others

Active not recruitingNaive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell TransplantThis phase II trial studies how well naive T-cell depletion works in preventing chronic graft-versus-host disease in children and young adults with blood cancers undergoing donor…NCT03779854·Los Angeles, California and 8 others

CompletedTofacitinib Ointment For Chronic Plaque PsoriasisThe study is beng done to test if tofacitinib ointment is safe and effective for people with plaque psoriasis.NCT01831466·Hot Springs, Arkansas and 53 others

CompletedPlatform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)This is a Phase 1 platform protocol designed to evaluate various targeted agents for the treatment of relapsed/refractory aggressive Non-Hodgkin's Lymphoma (NHL).NCT03527147·Los Angeles, California and 11 others

RecruitingCAR T-cell Therapy in Patients With Renal DysfunctionThis is a prospective, descriptive study designed to assess the feasibility of administering CAR T therapy among patients with moderate to severe renal impairment using dose…NCT05909059·Atlanta, Georgia

TerminatedPidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First RemissionThe purpose of this study is to evaluate pidilizumab and its effect, bad and/or good, on the immune system in relation to its ability to fight cancer cells.NCT02530125·Augusta, Georgia and 1 other

RecruitingA Study of LY4584180 in Adult Participants With Previously Treated Blood CancersThe main purpose of this study is to evaluate safety and efficacy, and measure how much LY4584180 gets into the bloodstream and how long it takes the body to eliminate it in…NCT07226843·Scottsdale, Arizona and 45 others

Other Conditions in Georgia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia